AMNEAL PHARMS LLC FDA Approval ANDA 215572

ANDA 215572

AMNEAL PHARMS LLC

FDA Drug Application

Application #215572

Application Sponsors

ANDA 215572AMNEAL PHARMS LLC

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2022-07-11UNKNOWN

Submissions Property Types

ORIG1Null31

CDER Filings

AMNEAL PHARMS LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215572
            [companyName] => AMNEAL PHARMS LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"SPIRONOLACTONE","activeIngredients":"SPIRONOLACTONE","strength":"25MG\/5ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/11\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"UNKNOWN","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-07-11
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.